Cannabis Strategic Ventures Stock Fundamentals
| NUGS Stock | USD 0.0001 0.00 0.00% |
Cannabis Strategic Ventures fundamentals help investors to digest information that contributes to Cannabis Strategic's financial success or failures. It also enables traders to predict the movement of Cannabis Pink Sheet. The fundamental analysis module provides a way to measure Cannabis Strategic's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cannabis Strategic pink sheet.
Cannabis |
Cannabis Strategic Ventures Company Return On Asset Analysis
Cannabis Strategic's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Cannabis Strategic Return On Asset | -0.2 |
Most of Cannabis Strategic's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cannabis Strategic Ventures is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Cannabis Strategic Ventures has a Return On Asset of -0.1963. This is 97.76% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on asset for all United States stocks is 40.21% higher than that of the company.
Cannabis Strategic Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cannabis Strategic's current stock value. Our valuation model uses many indicators to compare Cannabis Strategic value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cannabis Strategic competition to find correlations between indicators driving Cannabis Strategic's intrinsic value. More Info.Cannabis Strategic Ventures is considered to be number one stock in return on asset category among its peers. It also is considered to be number one stock in profit margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cannabis Strategic's earnings, one of the primary drivers of an investment's value.Cannabis Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cannabis Strategic's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Cannabis Strategic could also be used in its relative valuation, which is a method of valuing Cannabis Strategic by comparing valuation metrics of similar companies.Cannabis Strategic is currently under evaluation in return on asset category among its peers.
Cannabis Fundamentals
| Return On Asset | -0.2 | |||
| Profit Margin | (0.39) % | |||
| Operating Margin | (0.36) % | |||
| Current Valuation | 25.44 M | |||
| Shares Outstanding | 268.88 M | |||
| Price To Book | 113.91 X | |||
| Price To Sales | 0.26 X | |||
| Revenue | 14.6 M | |||
| Gross Profit | 2.78 M | |||
| EBITDA | (4.93 M) | |||
| Net Income | (5.64 M) | |||
| Cash And Equivalents | 402.8 K | |||
| Total Debt | 21.67 M | |||
| Current Ratio | 0.21 X | |||
| Book Value Per Share | (0.03) X | |||
| Cash Flow From Operations | (4.09 M) | |||
| Earnings Per Share | (0.02) X | |||
| Number Of Employees | 30 | |||
| Beta | 1.34 | |||
| Market Capitalization | 3.54 M |
About Cannabis Strategic Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cannabis Strategic Ventures's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cannabis Strategic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cannabis Strategic Ventures based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Cannabis Strategic Ventures engages in the cultivation of marijuana products in the United States. It incubates, develops, and partners within the cannabis and ancillary sectors. CANNABIS STRATEGIC operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 30 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cannabis Pink Sheet Analysis
When running Cannabis Strategic's price analysis, check to measure Cannabis Strategic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannabis Strategic is operating at the current time. Most of Cannabis Strategic's value examination focuses on studying past and present price action to predict the probability of Cannabis Strategic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannabis Strategic's price. Additionally, you may evaluate how the addition of Cannabis Strategic to your portfolios can decrease your overall portfolio volatility.